PatientsLikeMe Unveils New Tool to Match Patients With Clinical Trials Worldwide

The U.S.-based patient network and real-time research platform PatientsLikeMe unveils its global clinical trials tool today at Europe's Healthcare Innovation Expo 2013, hosted by the National Health Service (NHS). The free tool, unveiled today by Research Director Paul Wicks Ph.D., draws on open data to match patients from around the globe with clinical trials based on their condition and location. The U.S. prototype was launched last year and has already helped thousands of patients find suitable clinical trials. The tool is available at http://www.patientslikeme.com/clinical_trials.
"Open data helps us accelerate the pace of research, and it's crucial we do everything possible to match patients to trials that might advance treatment and help them live better with their condition," says Wicks, a newly named TED Fellow and UK scientist. "We're excited to be at this year's Expo to learn what British and European healthcare innovation has in store for the NHS."
Last week, PatientsLikeMe Co-founder and Chairman Jamie Heywood spoke about innovative solutions to healthcare at the 2013 Nuffield Trust Health Policy Summit in London. Nuffield Trust is an independent source of evidence-based research and policy analysis for improving health care in the UK. Heywood returns to London tomorrow to speak on the Expo's Masterclass Stage about the importance of measurement in building a learning health system.
In his Nuffield speech, Heywood called for a "revolution in measurement," or what he calls "measurement-based medicine." He adds, "We should measure the severity of each condition and its impact on the patient. The measurement should support the patient in life choices, clinicians in care choices and researchers in learning what's effective. And every patient should be measured as part of the care process to the degree appropriate for the severity of their condition, so that their experience can be used to guide the next patient."
About PatientsLikeMe
PatientsLikeMe is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers and nonprofits develop more effective products, services and care. PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 30 peer-reviewed research studies. Visit us at www.patientslikeme.com or follow us on our blog, on Twitter or via Facebook.

CONTACT:

Lori Scanlon
Office: +1 617.229.6643
Mobile: +1 774.217.1330
lscanlon@patientslikeme.com

Source:
PatientsLikeMe Unveils New Tool to Match Patients With Clinical Trials Worldwide

See also:

Art Kallow Selected as a Thought Leader for Upcoming Thomson Reuters Family Law Book
Attorney Art Kallow of the internationally respected firm, The Law Offices of Jeffery M. Leving, Ltd. has been invited to write a thought leadership essay for the new Aspatore Inside the Minds book,...

Report: Only 50% of UK Top 100 Online Retailers Websites Have Optimized for Mobile vs 100% of US
Skava, the leading provider of multi-touch point retail technology, today announced that as part of a recent study, only half of the top 100 UK retailers have optimized their websites for mobile...

MusclePharm to Present at the Peak to Peak Institutional Conference
MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, is proud to announce the Company will be presenting at the 2013 Peak to Peak Institutional...

46 Cancer Moms Help Their Children Feel "Normal" and Raise $1 Million in the Process

Nashville, TN, February 26, 2013 In May 2009, Miranda Beamer celebrated her fifth birthday. She was barely a year out of treatment for Ewings Sarcoma, a rare childhood cancer. As Miranda blew out her candles, her mom Tiffany Beamer set a goal to raise one million dollars for childhood cancer. Tiffany rallied Cancer Moms nationwide and formed 46 Mommas. 46 months later, on February 24, 2013, that goal was finally reached.

The number 46 is important, says Tiffany Beamer, the founder of the 46 Mommas team. Every week day, 46 children are diagnosed with cancer; every year, 46 new mommas shave for the brave. Our children lose their hair by treatment, we lose ours by choice.

Officially, the mommas shave for the St. Baldricks Foundation, the largest private funder of childhood cancer research. Unofficially, they shave for their children, as each momma has been touched by the ravages of childhood cancer. Since the mommas inaugural shave in September 2010, 138 different cancer moms have shaved for the team, 46 at a time. By the end of this June, another 46 will shave, bringing the official tally of mommas to 184.

In the United States, more than 13,000 children are diagnosed with cancer every year. Of those, 20%, or about 2,500, lose their lives, making childhood cancer the number cause of death by disease for children and adolescents in America.

While most of the children lose their lives to cancer, some are victims of the treatments they go through, most of which were originally formulated in the 1970s. Until a few years ago, there had been no new drugs designed solely for the treatment of childhood cancer in more than 30 years. Those that do survive the treatment often suffer complications, even decades after the end of treatment.

About 46 Mommas
46 Mommas Shave for the Brave team is a grassroots group of women who have shaved their heads for St Baldricks to raise money and awareness for childhood cancer. The group was started by Tiffany Beamer in 2009. The mommas shaved for the first time in September 2010. To date, 138 mommas have officially shaved for the team, with dozens more organizing events to help in their fundraising efforts.

The 2013 team of 46 Mommas will shave this year on June 30, 2013 at the Arneson River Walk Theater in San Antonio, Texas.

About St. Baldricks Foundation
The St. Baldricks Foundation is a volunteer-driven charity committed to funding the most promising research to find cures for childhood cancers and give survivors long and healthy lives. Since 2005, St.Baldricks has awarded more than $103 million to support lifesaving research, making the Foundation the largest private funder of childhood cancer research grants. St. Baldricks funds are granted to some of the most brilliant childhood cancer research experts in the world and to younger professionals who will be the experts of tomorrow. Funds awarded also enable hundreds of local institutions to participate in national pediatric cancer clinical trials. For more information about the St. Baldricks Foundation please call 1.888.899.BALD or visit www.StBaldricks.org.
# # #
If you would like more information about this topic, please contact Tiffany Beamer at 615.646.9665 or email at tbeamer(at)comcast.net

Contact Info
Tiffany F Beamer
7053 Meadow Ridge Circle
Nashville, TN 48

Phone: 6156469665

Website: http://www.

Source:
46 Cancer Moms Help Their Children Feel "Normal" and Raise $1 Million in the Process

See also:

Agilent Technologies Helps Students Acquire Real-World EDA Skills with New Licensing Program
SANTA CLARA, Calif.Agilent Technologies Inc. (NYSE: A) today launched the Agilent EEsof EDA Student License Program, designed to provide access to Agilent EEsof EDA software on students personal...

PPR announces that Redcats has entered into an agreement with Nordic Capital Fund VII for the sale of Ellos and Jotex
PPR announces that Redcats has entered into an agreement to sell its Nordic brands Ellos and Jotex to Nordic Capital Fund VII for an enterprise value of 275 million.Ellos is the leading home shopping...

Geneva 2013. Alfa 4C, pure sportiness
Alfa Romeo returns to the Geneva Motor Show with a spectacular booth that unfolds like a winding, dynamic road, the ideal place to present the world premi?re of the Alfa Romeo 4C, the ?compact...

Today's Technical View on JCP, M and KSS

Equity markets re-opened on Tuesday following a long weekend. Stocks rose sharply on Tuesday as sentiment was lifted by some robust German economic data. All three benchmark indexes posted gains, with the S&P 500 and the Dow Jones finishing at five-year highs. At the end of Tuesday's trading session, our research team took notice of J. C. Penney Company Inc. (NYSE: JCP), Macy's Inc. (NYSE: M) and Kohl's Corp. (NYSE: KSS). Wall Street Active research team has completed free research on JCP, M and KSS. As a leading provider of free in depth reports and timely market updates, we invite you to sign up now at
http://www.wallstreetactive.com/register.php
J.C. Penney Shares Slip
Despite the sharp rise in the broad market, shares of retailer J.C. Penney slipped in Tuesday's trading session. The stock closed 0.96% lower at $19.61 on volume of 4.87 million. J.C. Penney's shares had struggled in 2012 as the company's financial performance deteriorated. The stock has been essentially flat this year, even as the S&P 500 has climbed 7.33%. The stock is still trading above its 50-day moving average though, which is a bullish signal. J.C. Penney's shares have been struggling to break through $20 resistance level in the last few trading sessions. The stock currently has strong support at around $19. Sign up today and get useful insight about JCP for free at
http://www.wallstreetactive.com/register.php
Macy's Shares Rise Sharply
Macy's shares rose sharply on Tuesday. The stock rose 3.35% to finish the day at $40.43 on above average volume of 5.81 million. The sharp rise on significant volume suggests that market sentiment has turned bullish on Macy's. The bullish trend is further confirmed by the MACD chart. The stock's MACD has just moved above the signal line. The stock is also trading above its 50-day and 200-day moving averages. Year-to-date, shares have gained 3.61%, underperforming the S&P 500. The stock is now trading close to $40.50 resistance level. The next resistance level for the stock is at $41. Macy's shares have support at around $39. Free report on M can be accessed by registering at
http://www.wallstreetactive.com/register.php
Kohl's Shares Rise Marginally
Kohl's shares rose marginally in Tuesday's trading session. The stock hit an intra-day high of $46.84 before finishing the day 0.30% higher at $46.48 on above average volume of 3.17 million. Kohl's shares have had an excellent run this year, gaining more than 8%. The stock is currently trading above its 50-day and 200-day moving averages, which is a bullish signal. In the last few weeks, Kohl's shares have been struggling to break through $47 resistance level. The stock currently has support at $46. Register with Wall Street Active and download the research on KSS for free at
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com

Source:
Today's Technical View on JCP, M and KSS

See also:

MYL, AVNR and ACT -- Pre-Market Briefing
The Dow Jones and the S&P 500 finished at multi-year highs on Tuesday. The Dow Jones closed 0.39% higher at 14,035.67, the S&P 500 closed 0.73% higher at 1,530.94, and the NASDAQ closed 0.68%...

Fundamental Outlook on TGT, COST and FDO
Following a long weekend, stocks edged higher in Tuesday's trading session as sentiment was lifted by robust German economic data and a rise in M&A activity. The Dow Jones closed 0.39% higher at...

Pre-Market Update on JOY, MTW and AGCO
Markets in the U.S. re-opened after a long weekend. On Friday, stocks had finished on a mixed note as investors remained cautious ahead of the G20 summit, which was held in Moscow over the weekend. At...

Pre-Market Update on JOY, MTW and AGCO

Markets in the U.S. re-opened after a long weekend. On Friday, stocks had finished on a mixed note as investors remained cautious ahead of the G20 summit, which was held in Moscow over the weekend. At the close, our research team took notice of Joy Global Inc. (NYSE: JOY), Manitowoc Co. Inc. (NYSE: MTW) and AGCO Corp. (NYSE: AGCO). Wall Street Active research team has completed free research on JOY, MTW and AGCO. As a leading provider of free in depth reports and timely market updates, we invite you to sign up now at
http://www.wallstreetactive.com/register.php
Joy Global Shares Down Sharply This Year
Joy Global has been one of the worst performing stocks this year. Year-to-date, shares of the Wisconsin-based company have fallen nearly 30%. On Tuesday, the stock edged higher after the company declared a quarterly cash dividend of $0.175 per share. Joy Global's shares ended the day 1.08% higher at $63.54 on above average volume of 3.22 million. Over the last one week, Joy Global's shares have made a recovery after bottoming out at around $61.50. The stock is now trading close to its $64 resistance level. Recent volume activity suggests that the market sentiment has turned bullish on the stock. Sign up today and get useful insight about JOY for free at
http://www.wallstreetactive.com/register.php
Manitowoc Co. Shares Edge Higher
Manitowoc's shares rose sharply in Tuesday's trading session, tracking gains in the broad equity market. The stock ended the day 1.38% higher at $19.77 on volume of 2.32 million. The company's shares rose to an intra-day high of $19.77, which is close to the stock's 52-week high of $19.90. Year-to-date, the stock has gained 26.08%, easily outperforming the S&P 500, which is up 7.33% in the same period. Manitowoc's shares, in fact, have had an excellent run since November last year. The stock has seen a series of highs over the last three months, which is a strong bullish signal. The bullish trend is further confirmed by the MACD chart. Free report on MTW can be accessed by registering at
http://www.wallstreetactive.com/register.php
AGCO's Shares Also Gain
Shares of AGCO Corporation also edged higher in Tuesday's trading session. The stock closed 0.34% higher at $53.86 on volume of 736,225. AGCO Corporation shares have been trading sideways over the past few trading sessions. The stock has been struggling to break through $55 resistance level. It currently has support at around $53. Register with Wall Street Active and download the research on AGCO for free at
http://www.wallstreetactive.com/register.php
Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.

Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com

Source:
Pre-Market Update on JOY, MTW and AGCO

See also:

OSC Approves Release of Academy's Shares from Escrow
ACADEMY EXPLORATIONS LIMITED ("Academy" or the "Company"). On August 31, 2012, the Ontario Securities Commission approved the Company's request in Ontario to amend an existing escrow agreement among...

MYL, AVNR and ACT -- Pre-Market Briefing
The Dow Jones and the S&P 500 finished at multi-year highs on Tuesday. The Dow Jones closed 0.39% higher at 14,035.67, the S&P 500 closed 0.73% higher at 1,530.94, and the NASDAQ closed 0.68%...

Fundamental Outlook on TGT, COST and FDO
Following a long weekend, stocks edged higher in Tuesday's trading session as sentiment was lifted by robust German economic data and a rise in M&A activity. The Dow Jones closed 0.39% higher at...

Institutional Investor Releases Its 2013 All Europe Fixed-Income Research Team Survey Results

Tuesday, February 12, 2013 Institutional Investor has released the results of its 2013 All Europe Fixed Income Research Team survey. J.P. Morgan captures the top spot in the ranking for a third year running, while Barclays repeats at No. 2. Complete survey results can be found by visiting, http://bit.ly/12o7eMB.

Europes ongoing sovereign-debt crisis has driven demand for sell-side Investment research and helped fuel voter participation in this years survey. Nearly 800 investment professionals from some 380 buy-side institutions cast votes; those figures are up approximately 45 percent and 27 percent, respectively, from 2012.

Each of this years top five firms J.P. Morgan, Barclays, Bank of America Merrill Lynch, Deutsche Bank and Morgan Stanley, respectively captures more total team positions this year than they did in 2012. Bank of America Merrill Lynch is the real standout; its team-position total more than doubled, from six to 13.

This years results also include two firms making their first appearance on the All-Europe Fixed-Income Research Team: Crdit Agricole Corporate Investment Bank (tied for No. 10) and UniCredit (No. 13).

The trend toward cross-asset-class investing has accelerated in the wake of the global financial meltdown, and several analysts who appear on this team also rank on its equity counterpart, the 2013 All-Europe Research Team, whose winners were announced last week, and can be found by visiting: http://bit.ly/iimagAERT.

For more information, please contact Alyssa Walker at awalker@iiresearchgroup.com or (212) 224-3677.

About Institutional Investor
Now entering its fifth decade, Institutional Investor has consistently distinguished itself among the worlds foremost financial publications with groundbreaking journalism and incisive writing that provides essential intelligence for a global audience. In addition, Institutional Investor offers a host of proprietary research and rankings that serve as respected industry benchmarks. For more information, please visit http://bit.ly/aboutiimag.

Alyssa Walker
Institutional Investor
225 Park Avenue South
New York NY, 10003
212-224-3677

Source:
Institutional Investor Releases Its 2013 All Europe Fixed-Income Research Team Survey Results

See also:

New Book on Harnessing the Curative Power of Natures Fresh Air for Physical & Mental Wellbeing
SINGAPORE New kindle book The Truth about Air Electricity & Health: A guide on the use of air ionization and other natural approaches for 21st century health issues...

Purple Leads Providing High Conversion Pay Per Click Leads
Purple Leads is happy to announce that it now offers the Internets best Pay Per Click leads generation services. Pay Per Click (PPC) campaigns have some of the best conversion rates on the internet in...

Thermal Technology Ships 14 K1 Sapphire Crystal Growers to Europe
Thermal Technology, a leading manufacturer of crystal growth equipment and high temperature furnace systems, recently shipped 14 K1 HB LED-grade sapphire crystal growers to a customer in Europe. The...

Virginia Tech Expands Sports Concussion-Risk Studies to Include Hockey and Baseball

The Virginia Tech Wake Forest University School of Biomedical Engineering and Sciences is expanding its ground-breaking research of testing football helmets to reduce the number of concussions to now include hockey, baseball, softball, and lacrosse.

The five-year plan will see the Virginia Tech research center, headed by Stefan Duma, rate helmets worn by hockey, baseball, softball, and lacrosse athletes in their ability to lessen the likelihood of a concussion resulting from a violent head impact.

Ratings on hockey helmets are expected in fall 2013, followed by youth football in 2015, and then baseball, softball, and lacrosse in 2016. During that time, all ratings for adult and youth football helmets will continually be updated and released to the public.

The expansion into helmeted sports other than football comes on the heels of new research that allows for better prediction of sports-related concussions resulting from linear and rotational head accelerations. These accelerations result from head impacts that cause the head to translate and twist about the neck. The new research is published this month in the Annals of Biomedical Engineering.

(The peer-reviewed study is available online for free download from the journal.) http://link.springer.com/article/10.1007/s10439-012-0731-0 The new research is being funded by Virginia Tech, the National Highway Traffic Safety Administration, the National Institutes of Health, and the Institute for Critical Technology and Applied Science at Virginia Tech.

New ratings for football helmets will include data for linear and rotational accelerations starting in 2015, said Duma, professor of biomedical engineering and department head of the Virginia Tech Wake Forest University School of Biomedical Engineering and Sciences. Serving as lead author on the research paper is Steven Rowson, assistant professor of biomedical engineering at Virginia Tech.

All head impacts result in both linear and rotational accelerations, and this publication provides the foundation for our research to address both accelerations relative to reducing the risk of concussion, said Duma. Our goal with the five-year plan is to provide manufacturers with a schedule detailing when we will release helmet ratings for each sport.

The helmet rating system is based on more than a decade of data collection by Duma and his research staff, and utilizes the STAR, or Summation of Tests for the Analysis of Risk, formula that assesses the ability of football helmets to reduce concussion risk. Sport-specific testing methodologies will be added to the website that lists the rated helmets prior to the initial release of each sports helmets ratings.

Using data collected from more than 63,000 head impacts during a period of 10 years, Duma and Rowson related linear and rotational head acceleration to the probability of sustaining a concussion in the form of an injury risk function.

This new analysis utilizes data measured from 62 concussions sustained by high school, college, and professional football players, said Rowson. We use these data to determine the best method to predict concussions when we test helmets in our laboratory.

In their research paper, the researchers write, With as many as 3.8 million sports-related concussions occurring annually in the United States and research suggesting possible long term neurodegenerative processes resulting from repetitive concussions, reducing the incidence of concussion in sports has become a public health priority.

Indeed, long-term, repetitive injuries that can cripple or eventually kill years after play have prompted dozens of headlines in major media outlets and several national studies, and even President Obama to recently weigh in on the subject. Dozens of former NFL players are suing the league over injuries sustained during years of play, and headlines were made this summer when former football great Alex Karras died at age 77 from various ailments, several allegedly said to be caused by years of hard hits.

In studying football-related injuries during the past decade, Duma and his research team have used on-field real-time sensors installed in the helmets of hundreds of adult and youth football players to study injuries, as well as a mechanical lab-tested 5-star rating system to track and grade commercially sold helmets.

The former can help indicate head injuries that require immediate attention while on the field of play. The latter has provided the only independent biomechanical data for consumers to make helmet purchasing decisions, Duma said.

Dumas goal is not to end the sport of football, but make it safer while still keep the same expected adrenaline rush and action for players, and viewers.

It is important to note that no helmet can prevent all concussions. The most effective strategies to reduce concussions in sports involve modifying league rules and player technique to limit exposure to head impacts, Duma said.

Beyond this, head impacts are a given in sport. Our research focuses on identifying helmets that reduce concussion risk so that athletes can make informed decisions based on independent data when purchasing equipment, which in turn, incentivizes helmet manufacturers to design helmets that better reduce head acceleration.

News source: NewsWise

Source:
Virginia Tech Expands Sports Concussion-Risk Studies to Include Hockey and Baseball

See also:

Early Menopause May Occur In Women with BRCA Gene
Women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an...

Study Demonstrates Health Benefits of Coming Out of the Closet
Lesbians, gays and bisexuals (LGBs) who are out to others have lower stress hormone levels and fewer symptoms of anxiety, depression, and burnout, according to researchers at the Centre for Studies on...

Debunking the July Effect: Surgery Date Has Little Impact on Outcome
ROCHESTER, Minn. -- The July Effect -- the notion that the influx of new residents and fellows at teaching hospitals each July makes that the worse time of year to be a patient -- seems to be a myth,...

Debunking the July Effect: Surgery Date Has Little Impact on Outcome

ROCHESTER, Minn. -- The July Effect -- the notion that the influx of new residents and fellows at teaching hospitals each July makes that the worse time of year to be a patient -- seems to be a myth, according to new Mayo Clinic research that examined nearly 1 million hospitalizations for patients undergoing spine surgery from 2001 to 2008. Among those going under the knife, researchers discovered that the month surgery occurred had an insignificant impact on patient outcomes.

In addition, no substantial July Effect was observed in higher-risk patients, those admitted for elective surgery or patients undergoing simple or complex spinal procedures. The research was published online Tuesday in Journal of Neurosurgery: Spine.

We hope that our findings will reassure patients that they are not at higher risk of medical complications if they undergo spinal surgery during July as compared to other times of the year, says study co-author Jennifer McDonald, Ph.D., a Mayo Clinic radiologist. While we only looked at spinal surgeries, we think its likely wed find similar outcomes among other surgeries and procedures.

Researchers analyzed 2001 to 2008 data in the Nationwide Inpatient Sample, a large public database of information on hospitalized U.S. patients.

The researchers found that the incidents of all outcomes studied were higher in teaching hospitals, those with residents and fellows, than in nonteaching hospitals. In the teaching hospitals, minimally higher rates of postoperative infection and patient discharge to a long-term facility were found during July when compared with other months, but they were not high enough to establish a July Effect.

In-hospital deaths and postoperative complications did not differ according to the month of admission, the study found.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit www.mayoclinic.com and www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

News source: NewsWise

Source:
Debunking the July Effect: Surgery Date Has Little Impact on Outcome

See also:

February Birthstone Amethyst - The Jewellery Channel Unveils New Items
The February birthstone and zodiac sign of Pisceans is the captivating gem known as amethyst. These semi-precious jewels belonging to the quartz family are best known for their outstandingly rich...

Early Menopause May Occur In Women with BRCA Gene
Women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an...

Study Demonstrates Health Benefits of Coming Out of the Closet
Lesbians, gays and bisexuals (LGBs) who are out to others have lower stress hormone levels and fewer symptoms of anxiety, depression, and burnout, according to researchers at the Centre for Studies on...

Easterm Clinical Trials Moscow Russia Contract Research Organization Joins ACTO

On December 13, 2012 Eastern Clinical Trials (ECT), a contract research organization (CRO) with operations in Russia, Central and Eastern Europe, has been accepted into the Association of Clinical Trials Organizations (ACTO)."We are honored to become a part of ACTO, an organization consisting of the most reputable Pharmaceutical Companies and CROs operating in Russia", said Dr. Svetlana Vodolazhskaya, ECT's Managing Director. "We feel that it is important to support ACTO's ongoing interactions with the governmental agencies responsible for local clinical trial regulations and laws".

About Eastern Clinical Trials (ECT http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

About Association of Clinical Trial Organizations (ACTO http://www.acto-russia.org)
ACTO is a non-commercial organization of companies, legal entities and the clinical research community engaged in clinical trials in Russia.

Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana(dot)vodolazhskaya(at)easterntrials(dot)com

News source: PRWeb

Source:
Easterm Clinical Trials Moscow Russia Contract Research Organization Joins ACTO

See also:

Seasoned Business Expert Joins ARS as General Manager of San Diego Heating and Air Conditioning Business
ARS, a leading brand of American Residential Services and one of its premier heating and air conditioning service companies nationwide, is pleased to announce the addition of Art Hagopian as General...

Xocai Healthy Chocolate, a Delicious Healthy Chocolate Alternative, Announces Highest Earning Distributors Named to Top Producer's List By MXI Corp
Marketing Xocolate International Corporation (MXI-Corp) announces its top 10 producers, which is comprised of distributors who have achieved Executive level or higher with the highest earnings.This...

BLOOMBERG: Shadow Inventory Remains High in 2013
Bloomberg TV reports that the total shadow inventory could be as high as 3.67 million homes.Shadow inventory is a term used to describe homes that are purposely kept off the market, the motivation...

New Research Strengthens Connection between Oral and Overall Health, Says The American Academy for Oral Systemic Health

The American Academy for Oral Systemic Health (AAOSH) responds to recent research connecting oral inflammation and erectile dysfunction by encouraging further on-going research and stressing the importance of the oral-systemic health connection.

With each new study connecting oral inflammation with a host of life-threatening and life-altering diseases, we continue to see that oral-systemic health is a vital key to keeping our patients healthy and well, says Dr. Dan Sindelar, president of AAOSH. It is of great importance that these studies continue to find the latest connections between oral health and some of the most prevalent conditions that Americans face today.

The recent study published in the Journal of Sexual Medicine found that men with severe periodontal disease were more than three times more likely to suffer from erectile dysfunction that the men with healthy gums were. Head researchers concluded that periodontal disease should be considered a causative clinical condition of erectile dysfunction.

In addition, leading research continues to find connections between oral inflammation and degenerative brain conditions like Alzheimers disease and dementia as well as conditions like heart disease, strokes and diabetes.

This research adds to the mountain of evidence that oral inflammation doesnt just affect a patients mouth, but has a profound effect on his or her entire body, says Dr. Sindelar. The results of these studies are clear: We as dental professionals must continue to stay at the forefront of oral systemic health in order to optimize our patients overall health.

About AAOSH
The American Academy for Oral Systemic Health is an organization of health care leaders and health professionals dedicated to the relationship of oral health and whole body health. AAOSH membership includes and is open to health professionals from many allied health disciplines, corporate supporters and sponsors, health educators, and healthcare leaders. Understanding the emerging science-driven relationships between the mouth and the body, AAOSH promotes building closer ties between allied health professionals and improving interdisciplinary communication and professional referral relationships.

News source: PRWeb

Source:
New Research Strengthens Connection between Oral and Overall Health, Says The American Academy for Oral Systemic Health

See also:

New Study Reveals Sex to be Pleasurable With or Without Use of a Condom or Lubricant
Article: Reporter Follow-up">sciencenewsroom@wiley.comFull citation: Herbenick et al. Characteristics of Condom and Lubricant Use among a Nationally Representative Probability Sample of Adults Ages...

Purple Leads Offers Credit Repair Leads
Purple Leads is pleased to announce that it now offers credit restoration leads generation services. The current financial climate has put many, many people in need of credit help and repair services....

Digital Marketing Trends 2013: Internet Income University Shares Some Of The Top Marketing Strategies For The Year Ahead
The world of digital marketing has seen some major changes within the past few years and many are looking forward to the new digital marketing trends 2013 will bring. With new technology coming on the...

New Study Reveals Sex to be Pleasurable With or Without Use of a Condom or Lubricant

Article: Reporter Follow-up">sciencenewsroom@wiley.com

Full citation: Herbenick et al. Characteristics of Condom and Lubricant Use among a Nationally Representative Probability Sample of Adults Ages 18-59 In the United States

The Journal of Sexual Medicine 2013. DOI: 10.1111/jsm.12021
URL Upon publication: http://doi.wiley.com/10.1111/jsm.12021

About the Journal:
The Journal of Sexual Medicine (JSM) is a peer-reviewed publication founded in 2004 and is an official journal of the International Society for Sexual Medicine, its five regional affiliated societies and the International Society for the Study of Womens Sexual Health. It publishes multidisciplinary basic science and clinical research to define and understand the scientific basis of male, female, and couples sexual function and dysfunction and carries an Impact Factor of 3.957. For more information, please visit www.jsm.issm.info.

Download The JSM mobile app for free to your smartphone or iPad to keep up with the latest research published in The Journal of Sexual Medicine.

The International Society for Sexual Medicine (ISSM) was founded in 1982 for the purpose of promoting, throughout the international scientific community, research and knowledge in sexual medicine, considered as the subspecialty area of medicine that embraces the study, diagnosis and treatment of the sexual health concerns of men and women. The society has over 2,100 members worldwide, with five regional societies that are affiliated with ISSM: the Asia Pacific Society for Sexual Medicine, European Society for Sexual Medicine, Latin American Society for Sexual Medicine, the Middle East Society for Sexual Medicine, and Sexual Medicine Society of North America. For more information please visit www.issm.info.

About Wiley
Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace.

Wiley is a global provider of content and content-enabled workflow solutions in areas of scientific, technical, medical, and scholarly research; professional development; and education. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's Web site can be accessed at http://www.wiley.com. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.

News source: NewsWise

Source:
New Study Reveals Sex to be Pleasurable With or Without Use of a Condom or Lubricant

See also:

Make 2013 The Year You Clean Up Your Body - For Life
The brand new book Natural Body Detox: How To Naturally Detox Your Body For Healthy Weight Loss, Natural Detoxification and Healing by Sue Woledge is available to download for FREE on Amazon for a...

37 Crisis Management and Crisis Leadership Training and Education Tutorials Released
Effective crisis management and crisis leadership skills or ability are learnt and not naturally occurring for senior executives says Tony Ridley when asked about the release of the new 37 Crisis...

Travel Risk Management Safety and Security Tips Video Series Released
Business and leisure travel can be filled with excitement and opportunity but unfortunately, bad things happen to good people everyday. Therefore, all travel should be considered hazardous, until...

Men More Likely Than Women to Commit Scientific Fraud

January 22, 2013 (Bronx, NY) Male scientists are far more likely to commit fraud than females and the fraud occurs across the career spectrum, from trainees to senior faculty. The analysis of professional misconduct was co-led by a researcher at Albert Einstein College of Medicine of Yeshiva University and was published today in the online journal mBio.

The fact that misconduct occurs across all stages of career development suggests that attention to ethical aspects of scientific conduct should not be limited to those in training, as is the current practice, said senior author Arturo Casadevall, M.D., Ph.D., professor and chair of microbiology & immunology and professor of medicine at Einstein, as well as editor-in-chief of mBio.

He added, Our other finding that males are overrepresented among those committing misconduct implies a gender difference we need to better understand in any effort to promote the integrity of research.

In a previous study, Dr. Casadevall found that misconduct is responsible for two-thirds of all retractions of scientific papers. The finding was unexpected, since earlier research had suggested that errors account for the majority of retracted scientific papers.

Researchers embarked on the current study to better understand those who are guilty of scientific fraud. They reviewed 228 individual cases of misconduct reported by the United States Office of Research Integrity (ORI) from 1994 through 2012. ORI promotes the responsible conduct of research and investigates charges of misconduct involving research supported by the Department of Health and Human Services.

An analysis determined that fraud was involved in 215 (94 percent) of the 228 cases reported by the ORI. Of these, 40 percent involved trainees, 32 percent involved faculty members, and 28 percent involved other research personnel (research scientists, technicians, study coordinators, and interviewers).

Overall, 65 percent of the fraud cases were committed by males, but the percentage varied among the academic ranks: 88 percent of faculty members who committed misconduct were male, compared with 69 percent of postdoctoral fellows, 58 percent of students, and 43 percent of other research personnel. In each career category, the proportion of males committing misconduct was greater than would have been predicted from the gender distribution of scientists. The gender difference was surprisingly large among faculty, said Dr. Casadevall, who also holds the Leo and Julia Forchheimer Chair in/of Microbiology & Immunology. Of the 72 faculty who committed fraud, just 9 were female one-third of the expected 27 if females had committed fraud at the same rate as males.

The study did not examine why men are more likely to commit fraud. One possibility is that misconduct is biologically driven. As research has shown, males tend to be risk takers, more so than females, and to commit fraud entails taking a risk, said Dr. Casadevall. It may also be that males are more competitive, or that women are more sensitive to the threat of sanctions. I think the best answer is that we dont know. Now that we have documented the problem, we can begin a serious discussion about what is going on and what can be done about it.

The researchers had hypothesized that the majority of cases of misconduct would involve trainees, who face intense pressure to publish a critical step toward obtaining research funds. But they found that misconduct was spread rather evenly across the career spectrum. You might think that as scientists go up the career ladder, they would feel more secure. But the bigger the lab you run, the more grants you need, which increases the pressures to publish and the temptation to cheat, said Dr. Casadevall.

While calling for more research to understand the motives for scientific misconduct, Dr. Casadevall recommends periodic ethics training for scientists at all levels of academia. Right now we target trainees for ethics training, he added. We dont do anything after they are hired. It might help if universities required refresher courses in ethics, as they do with courses to prevent sexual harassment in the workplace. It wont stop all misconduct, but its one place to start.

The paper is titled "Males Are Overrepresented among Life Science Researchers Committing Scientific Misconduct. Additional authors are Ferric Fang, M.D., at the University of Washington School of Medicine, Seattle, Washington, and Joan W. Bennett at Rutgers University, New Brunswick, New Jersey.

The authors report no conflict of interest.

***

About Albert Einstein College of Medicine of Yeshiva University

Albert Einstein College of Medicine of Yeshiva University is one of the nations premier centers for research, medical education and clinical investigation. During the 2011-2012 academic year, Einstein is home to 724 M.D. students, 248 Ph.D. students, 117 students in the combined M.D./Ph.D. program, and 368 postdoctoral research fellows. The College of Medicine has 2,522 full time faculty members located on the main campus and at its clinical affiliates. In 2011, Einstein received nearly $170 million in awards from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center
Einsteins founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, Einstein runs one of the largest post-graduate medical training programs in the United States, offering approximately 155 residency programs to more than 2,200 physicians in training. For more information, please visit www.einstein.yu.edu and follow us on Twitter @EinsteinMed.

News source: NewsWise

Source:
Men More Likely Than Women to Commit Scientific Fraud

See also:

Make 2013 The Year You Clean Up Your Body - For Life
The brand new book Natural Body Detox: How To Naturally Detox Your Body For Healthy Weight Loss, Natural Detoxification and Healing by Sue Woledge is available to download for FREE on Amazon for a...

37 Crisis Management and Crisis Leadership Training and Education Tutorials Released
Effective crisis management and crisis leadership skills or ability are learnt and not naturally occurring for senior executives says Tony Ridley when asked about the release of the new 37 Crisis...

Travel Risk Management Safety and Security Tips Video Series Released
Business and leisure travel can be filled with excitement and opportunity but unfortunately, bad things happen to good people everyday. Therefore, all travel should be considered hazardous, until...

Better Syringe Designs Could Nearly Eradicate Global Annual HIV Infections from Syringe Sharing Within Eight Years

RESEARCH TRIANGLE PARK, N.C. Switching the type of syringe used by people who inject drugs could help curb HIV transmission in countries with injection-driven epidemics within eight years, according

The Top 10 Customer Service Trends for 2013

Technology and higher customer expectations are driving significant trends in customer service for 2013. Customer service training and consultancy firm, The Belding Group of Companies, identifies the